VACV-DSC1 mab (VH3I-0J7N) WT Cas9-ASGR1 for B Cell Engineering (CAT#: BGS-0524-CR198)

The product is a highly efficient, inducible WT Cas9-ASGR1 gene-editing based novel VACV packaging system that can be used to mediate researches involving anti-DSC1 mab (VH3I-0J7N) in Horse B cell engineering.

Datasheet

Specifications

Clone VH3I-0J7N
Host Humanized
Packaging Cell Line HEK 293
Vector Promoter CMV
Rep Rep68
Capsid P24
Envelope Env
Matrix C-terminal
Size ~30kb
Genome dsDNA
Virus Type VACV
Cofactor Requirement No ATP, CP, or CPK
Particles/mL 4.1 × 10¹¹
PFU/mL 9.3 × 10¹¹
TU/mL 4.7 × 10¹¹
Cas9 WT Cas9
sgRNA ASGR1
Engineered B Cell Horse B cells

Target Information

Target DSC1
Alternative Names DSC1; CDHF1; DG2/DG3; desmocollin 1

Product Properties

Format Liquid
Shipping The product is shipped by dry ice.
Storage Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles.
COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number
! For Research Use Only | Not For Clinical Use

Related products